@article{73ef00b3ac4947eb921303c050edc128,
title = "Thoracoabdominal Aortic Disease and Repair: JACC Focus Seminar, Part 3",
abstract = "Thoracoabdominal aortic disease is a rare but life-threatening condition that requires expert multidisciplinary collaborative management. Intervention is indicated in patients with symptomatic aneurysms or when an aneurysm reaches a certain threshold of diameter or rate of expansion. The strategies for spinal cord and end-organ protection have evolved over several decades, resulting in improved outcomes after repair. Open repair, although invasive, provides definitive and durable repair. Endovascular approaches are rapidly evolving, and the results with fenestrated and branched endografts are promising. Both open repair and endovascular repair require highly specialized expertise, and outcomes are best when repair is undertaken in an elective setting by a dedicated team. Patients with degenerative thoracoabdominal aortic aneurysms and chronic dissections should be followed up closely and referred for elective repair when indicated.",
keywords = "aortic aneurysm, dissection, endovascular, thoracoabdominal aneurysm",
author = "Maral Ouzounian and Tadros, {Rami O.} and Svensson, {Lars G.} and Lyden, {Sean P.} and Oderich, {Gustavo S.} and Coselli, {Joseph S.}",
note = "Funding Information: Dr Ouzounian has consulting agreements with Medtronic Inc and Edwards Lifesciences; and is partly supported by the Munk Chair in Advanced Therapeutics and the Antonio and Helga DeGasperis Chair in Clinical Trials and Outcomes Research at the University Health Network. Dr Tadros has taught courses for and received honoraria from Abbott Medical, Cook Medical, Gore Medical, Medtronic, and Terumo Interventional Systems. Dr Lyden has been a consultant with Endologix, Abbott, Boston Scientific, Centerline Biomedical, Medtronic, Shockwave, Penumba, Cryolife, and Philips. Dr Oderich has received research grants from and has had consulting agreements with Cook Medical, W.L. Gore, and G.E. Healthcare. Dr Coselli has participated in clinical studies and/or has been a consultant for Terumo Aortic, Medtronic, W. L. Gore & Associates, and CytoSorbents; has received royalties from Terumo Aortic; and is partly supported by an endowment from the Cullen Foundation. Dr Svensson has reported that he has no relationships relevant to the contents of this paper to disclose. Publisher Copyright: {\textcopyright} 2022 American College of Cardiology Foundation",
year = "2022",
month = aug,
day = "23",
doi = "10.1016/j.jacc.2021.05.056",
language = "English",
volume = "80",
pages = "845--856",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "8",
}